Therapeutic Asset Ratings

1,055 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Hydrocortisone T-Lymphoblastic Lymphoma	Children's Oncology Group	P2/3	CCC (55)
iah0968 Gastric Neoplasm	SUNHO（China）BioPharmaceutical CO., Ltd.	P2/3	CCC (55)
Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (human clone HER3.H3 single-chain variable fragment VH-(GGGGS)3-VL), complex with human-mouse monoclonal C225 ?-chain, dimer, 214??,214???,222,222?,228,228?,231,231?-octakis(thioether) with (2S)-N-(carboxymethyl)-2-(3-mercapto-2,5-dioxo-1-pyrrolidinyl)-?-alanylglycylglycyl-L-phenylalanyl-N-[[(1S)-2-[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3?,4?:6,7]indolizino[1,2-b]quinolin-1-yl]amino]-1-methyl-2-oxoethoxy]methyl]glycinamide Castration-Resistant Prostate Carcinoma	Sichuan Baili Pharmaceutical Co., Ltd.	P2/3	CCC (55)
Immunoglobulin G1 [de-449-lysine], anti-(human tau protein) (human-Mus musculus monoclonal E2814 ?1-chain), disulfide with human-Mus musculus monoclonal E2814 .kappa.-chain, dimer Dementia	Washington University School of Medicine	P2/3	CCC (55)
Immunoglobulin G4 [221-proline], anti-(human programmed cell death protein 1) (human monoclonal SG001 ?4-chain), disulfide with human monoclonal SG001 ?-chain, dimer Colorectal Cancer	Hebei Medical University Fourth Hospital	P2/3	CCC (55)
Iparomilimab Triple-Negative Breast Carcinoma	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	P2/3	CCC (55)
Letrozole Endometrial Cancer	Xiaojun Chen	P2/3	CCC (55)
lns8801 Cutaneous Melanoma	Linnaeus Therapeutics, Inc.	P2/3	CCC (55)
Mayzent Secondary Progressive Multiple Sclerosis	State University of New York at Buffalo	P2/3	CCC (55)
Methylphenidate Prostate Carcinoma	M.D. Anderson Cancer Center	P2/3	CCC (55)
Mitizodone Phosphate Tablets Major Depressive Disorder	Sunshine Lake Pharma Co., Ltd.	P2/3	CCC (55)
Mitoquinol mesilate Cognitive Disorder	Mclean Hospital	P2/3	CCC (55)
N-Acetyl-L-Cysteine Acute Kidney Injury	Fakultas Kedokteran Universitas Indonesia	P2/3	CCC (55)
Nerandomilast Amyotrophic Lateral Sclerosis	Gipfel Life Sciences GmbH	P2/3	CCC (55)
Nicorandil Type 2 Diabetes Mellitus	Tanta University	P2/3	CCC (55)
Nogapendekin Alfa Lung Cancer	SWOG Cancer Research Network	P2/3	CCC (55)
Nrx-101 Major Depressive Disorder	NeuroRx, Inc.	P2/3	CCC (55)
PEGASPARGASE T Lymphoblastic Leukemia/Lymphoma	Children's Oncology Group	P2/3	CCC (55)
Ponsegromab Pancreatic Ductal Adenocarcinoma	Pfizer	P2/3	CCC (55)
Pracytarabine Hepatocellular Carcinoma	Xi'an Xintong Pharmaceutical Research Co.,Ltd.	P2/3	CCC (55)
Recombinant Ephb4-Hsa Fusion Protein Infiltrating Bladder Urothelial Carcinoma	Vasgene Therapeutics, Inc	P2/3	CCC (55)
Recombinant Ephb4-Hsa Fusion Protein Urothelial Carcinoma	Vasgene Therapeutics, Inc	P2/3	CCC (55)
Recombinant Human Hyaluronidase Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma Of The Elderly	National Cancer Institute (NCI)	P2/3	CCC (55)
Recombinant Human Hyaluronidase High Grade B-Cell Lymphoma With MYC And/ Or BCL2 And/Or BCL6 Rearrangement	National Cancer Institute (NCI)	P2/3	CCC (55)
Recombinant Human Hyaluronidase Lymphoplasmacytic Lymphoma	National Cancer Institute (NCI)	P2/3	CCC (55)

Showing 751 to 775 of 1,055 assets

PreviousPage 31 of 43Next